Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…
ADHD Meds Offer Benefits Far Beyond Core Symptom Relief
Attention-deficit/hyperactivity disorder (ADHD) medications appeared to reduce the risk for suicide, drug misuse, transport incidents, and criminal activity,…
FDA Approves Tonix’s Tonmya for Fibromyalgia, First New Drug in 15 Years
Tonix Pharmaceuticals (Nasdaq: TNXP) has received FDA approval for Tonmya™,…
Double trouble: gene-regulating duo shapes cell fate and disease
Newswise — CLEVELAND—Shedding light on what determines how cells become what they are meant to be—nerves, bone, muscles,…
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…
Ultra-processed foods make up a big portion of Americans’ diet, CDC finds
Most Americans get more than half their calories from ultra-processed foods, those super-tasty, energy-dense foods typically full of…